{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:04:44Z","timestamp":1774962284647,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.remnie.2026.500309","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:03:19Z","timestamp":1773759799000},"page":"500309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic impact of 18F-PSMA-1007 PET\/MRI in staging intermediate\/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness"],"prefix":"10.1016","author":[{"given":"J.R.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Compte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.L.","family":"Mont-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garcia Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Santab\u00e1rbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mourelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Riera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2026.500309_bib0005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/bjr\/tqae021","article-title":"Clinical value of 18F-PSMA-1007 PET\/MRI in primary staging of patients with intermediate to high-risk prostate cancer","volume":"97","author":"Ismail Ali","year":"2024","journal-title":"BJR"},{"key":"10.1016\/j.remnie.2026.500309_bib0010","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2967\/jnumed.122.263897","article-title":"68Ga-PSMA-11 PET\/MRI in newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment","volume":"63","author":"Moradi","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2026.500309_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110044","article-title":"Primary staging in intermediate and high-risk prostate cancer: mpMRI and 68Ga-PSMA PET\/MRI\u2014value of quantitative mpMRI alone or with clinical information","volume":"146","author":"Skawran","year":"2022","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.remnie.2026.500309_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13244-022-01217-4","article-title":"Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate to high-risk patients","volume":"13","author":"Laudicella","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.remnie.2026.500309_bib0025","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3390\/diagnostics15182405","article-title":"Impact of 68Ga-PSMA PET\/MRI on the accuracy of MRI derived grading systems for predicting extraprostatic extension in prostate cancer","volume":"15","author":"Uslu Be\u015fli","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.remnie.2026.500309_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13244-024-01876-5","article-title":"Preoperative detection of extraprostatic tumor extension utilizing [68Ga]Ga-PSMA-11 PET\/MRI","volume":"15","author":"Spielvogel","year":"2024","journal-title":"Insights Imaging"},{"issue":"8","key":"10.1016\/j.remnie.2026.500309_bib0035","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2967\/jnumed.118.221564","article-title":"68Ga-PSMA-11 PET\/MR detects local recurrence occult on mpMRI in prostate cancer patients after HIFU","volume":"60","author":"Burger","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2026.500309_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2024.11.006","article-title":"Baseline Nodal Status on (68)Ga-PSMA-11 PET\/CT in men with intermediate- to high-risk prostate cancer is prognostic for treatment failure: follow-up of the proPSMA trial","author":"Hofman","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.remnie.2026.500309_bib0045","article-title":"Evaluaci\u00f3n de la tasa de detecci\u00f3n de la recidiva local y de cuerpo completo mediante la valoraci\u00f3n integrada de la PET\/RM con [18F]F-PSMA-1007 de pacientes con c\u00e1ncer de pr\u00f3stata tratados con prostatectom\u00eda con recidiva bioqu\u00edmica muy baja (<0,5 ng\/ml)","volume":"43","author":"Garc\u00eda","year":"2024","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remnie.2026.500309_bib0050","first-page":"527","article-title":"The added value of PSMA PET\/MR radiomics for prostate cancer staging","volume":"49","author":"Solari","year":"2022","journal-title":"EJNMMI"},{"key":"10.1016\/j.remnie.2026.500309_bib0055","first-page":"72","article-title":"18F-choline PET\/MR in the initial staging of prostate cancer. Impact on the therapeutic approach","volume":"40","author":"Garc\u00eda","year":"2021","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remnie.2026.500309_bib0060","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of PSMA PET\/CT to mpMRI Triage in the Diagnosis of Prostate Cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.remnie.2026.500309_bib0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.remnie.2026.500309_bib0070","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s00261-024-04738-2","article-title":"PSMA-RADS to improve evaluation and management of prostate cancer","volume":"50","author":"Rafiei Alavi","year":"2025","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"10.1016\/j.remnie.2026.500309_bib0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41391-020-00292-2","article-title":"Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to mpMRI and histopathology","volume":"24","author":"Prive","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"24","key":"10.1016\/j.remnie.2026.500309_bib0080","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/1078-0432.CCR-18-0768","article-title":"PSMA ligand PET\/MRI for primary prostate cancer: staging performance and clinical impact","volume":"24","author":"Grubm\u00fcller","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.remnie.2026.500309_bib0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1148\/radiol.2018181278","article-title":"A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI","volume":"290","author":"Mehralivand","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.remnie.2026.500309_bib0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jmri.25384","article-title":"Diagnostic value of integrated PET\/MRI for detection and localization of prostate cancer: comparative study of mpMRI and PET\/CT","volume":"45","author":"Lee","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.remnie.2026.500309_bib0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of MRI for local staging of prostate cancer: a diagnostic meta-analysis","volume":"70","author":"de Rooij","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2026.500309_bib0100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/1754-9485.13084","article-title":"Tumour\u2013capsule interface measured on 18F-DCFPyL PSMA PET\/CT imaging comparable to mpMRI in predicting extra-prostatic extension","volume":"64","author":"Brauchli","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"2","key":"10.1016\/j.remnie.2026.500309_bib0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1148\/radiol.2019190687","article-title":"Diagnostic accuracy of mpMRI versus Ga-PSMA-11 PET\/MRI for extracapsular extension and seminal vesicle invasion","volume":"293","author":"Muehlematter","year":"2019","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.remnie.2026.500309_bib0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.euo.2020.06.012","article-title":"A prospective comparison of 18F-PSMA-1007 PET\/CT, whole-body MRI, and SPECT\/CT in primary distant metastasis staging of prostate cancer (PROSTAGE)","volume":"4","author":"Anttinen","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.remnie.2026.500309_bib0115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s13139-017-0476-7","article-title":"68Ga-PSMA PET\/CT imaging predicting intraprostatic tumor extent, extracapsular extension and seminal vesicle invasion prior to radical prostatectomy","volume":"51","author":"von Klot","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2026.500309_bib0120","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00259-020-05140-y","article-title":"Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET\/MRI","volume":"48","author":"Papp","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808926000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808926000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:08:44Z","timestamp":1774958924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808926000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"alternative-id":["S2253808926000376"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2026.500309","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic impact of 18F-PSMA-1007 PET\/MRI in staging intermediate\/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2026.500309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2026.500309","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular.","name":"copyright","label":"Copyright"}],"article-number":"500309"}}